Corteva (NYSE:CTVA) Price Target Raised to $96.00

Corteva (NYSE:CTVA) had its price objective raised by The Goldman Sachs Group from $88.00 to $96.00 in a research note issued to investors on Tuesday morning,MarketScreener reports. They currently have a buy rating on the stock.

CTVA has been the subject of several other reports. Wolfe Research upped their target price on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Royal Bank Of Canada upped their target price on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Citigroup increased their price objective on Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Finally, BNP Paribas Exane increased their price objective on Corteva from $72.00 to $74.00 in a research note on Monday, March 9th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Corteva presently has a consensus rating of “Moderate Buy” and an average target price of $84.52.

Corteva Stock Down 0.2%

NYSE CTVA opened at $81.12 on Tuesday. The business has a 50 day moving average price of $79.40 and a two-hundred day moving average price of $70.96. Corteva has a fifty-two week low of $58.58 and a fifty-two week high of $85.63. The stock has a market cap of $54.46 billion, a PE ratio of 51.34, a P/E/G ratio of 2.78 and a beta of 0.68. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s revenue was down 1.7% compared to the same quarter last year. During the same period in the prior year, the company posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts predict that Corteva will post 2.96 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 16th. Stockholders of record on Monday, March 2nd were given a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Insider Activity

In other Corteva news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider directly owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.15% of the company’s stock.

Hedge Funds Weigh In On Corteva

Several large investors have recently made changes to their positions in the company. Activest Wealth Management increased its holdings in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC bought a new stake in shares of Corteva in the third quarter worth about $25,000. True Wealth Design LLC increased its holdings in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock worth $26,000 after acquiring an additional 264 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva in the fourth quarter worth about $27,000. Finally, Bank of Jackson Hole Trust bought a new stake in shares of Corteva in the fourth quarter worth about $28,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.